Search by Drug Name or NDC
NDC 62135-0141-57 Benztropine Mesylate 0.5 mg/1 Details
Benztropine Mesylate 0.5 mg/1
Benztropine Mesylate is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Chartwell RX, LLC.. The primary component is BENZTROPINE MESYLATE.
Product Information
| NDC | 62135-0141 |
|---|---|
| Product ID | 62135-141_f29febd6-5a0e-eb83-e053-2a95a90a5b7d |
| Associated GPIs | |
| GCN Sequence Number | 004589 |
| GCN Sequence Number Description | benztropine mesylate TABLET 0.5 MG ORAL |
| HIC3 | H6B |
| HIC3 Description | ANTIPARKINSONISM DRUGS,ANTICHOLINERGIC |
| GCN | 17620 |
| HICL Sequence Number | 001905 |
| HICL Sequence Number Description | BENZTROPINE MESYLATE |
| Brand/Generic | Generic |
| Proprietary Name | Benztropine Mesylate |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Benztropine mesylate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 0.5 |
| Active Ingredient Units | mg/1 |
| Substance Name | BENZTROPINE MESYLATE |
| Labeler Name | Chartwell RX, LLC. |
| Pharmaceutical Class | Anticholinergic [EPC], Antihistamine [EPC], Cholinergic Antagonists [MoA], Histamine Receptor Antagonists [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA081265 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 62135-0141-57 (62135014157)
| NDC Package Code | 62135-141-57 |
|---|---|
| Billing NDC | 62135014157 |
| Package | 540 TABLET in 1 BOTTLE (62135-141-57) |
| Marketing Start Date | 2022-09-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |